Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-07

Clinical Trial Update: Folinic Acid in Children With Autism Spectrum Disorders [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining folinic acid in children with autism spectrum disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Folinic acid (folinic acid)

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Autism Spectrum Disorder | Phase 2 | Status: UNKNOWN